Mammoth Hibernation is a research blend of three peptides in one lyophilized vial: DSIP (delta sleep-inducing peptide), KPV and Selank. The three have very different origins, and each has its own published research. No published study has looked at them together.
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Components
| Component | Amount per vial | What it is |
|---|---|---|
| DSIP | 10 mg | Nine-amino-acid peptide first isolated from rabbit blood |
| KPV | 10 mg | Tripeptide Lys-Pro-Val from the end of alpha-MSH |
| Selank | 10 mg | Seven-amino-acid synthetic analogue of tuftsin |
DSIP (delta sleep-inducing peptide)
| Property | Value |
|---|---|
| Sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE) |
| Length | 9 amino acids (nonapeptide) |
| Molecular formula | C₃₅H₄₈N₁₀O₁₅ |
| Molecular weight | ~848.8 g/mol |
| Other names | Emideltide |
DSIP was isolated in the 1970s by a Swiss group, from the cerebral venous blood of sleeping rabbits. The name comes from that original experiment. It does not describe a confirmed function.
What research has looked at. Early work measured changes in EEG delta activity in rabbits. Later studies, mostly from the 1980s and 1990s, looked at DSIP in relation to stress responses, body temperature, hormone release (including corticotropin and luteinizing hormone), and opioid and alcohol withdrawal models.
Limits. Results across studies are inconsistent. No DSIP gene, precursor protein or dedicated receptor has been identified, and a widely cited review called the peptide “a still unresolved riddle”. Long-term safety has not been established. DSIP is not approved by the FDA.
KPV
KPV (Lys-Pro-Val) is the last three amino acids of alpha-melanocyte-stimulating hormone (alpha-MSH). It has been studied mainly in mouse models of intestinal inflammation (chemically induced colitis) and in intestinal cell cultures. That work suggests the peptide is taken up through the PepT1 transporter. Several groups have also studied nanoparticle delivery of KPV in these models. KPV research overview
Selank
| Property | Value |
|---|---|
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP) |
| Length | 7 amino acids (heptapeptide) |
| Molecular formula | C₃₃H₅₇N₁₁O₉ |
| Molecular weight | ~751.9 g/mol (free peptide; the acetate salt is heavier) |
| Other names | TP-7 |
Selank was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is based on tuftsin (Thr-Lys-Pro-Arg), a short fragment of the immunoglobulin G heavy chain. A Pro-Gly-Pro tail was added to make the peptide more stable.
What research has looked at.
- Behavioural models. Anxiety-related behaviour and stress responses in rats and mice, including studies alongside benzodiazepines.
- Gene expression. Changes in the expression of genes involved in GABA signalling, measured in rat brain tissue and in cultured nerve-cell lines.
- Enzymes and signalling. Inhibition of enkephalin-degrading enzymes in serum, and effects on monoamines and on BDNF expression in the rat hippocampus.
- Immune markers. Cytokine changes, which link back to tuftsin’s immune activity.
Status. Selank is registered as a medicine (an anxiolytic) in the Russian Federation, and most of the clinical literature is Russian. Sources disagree on when it was approved: some say 2009, others say the early 1990s. It is not approved by the FDA.
Research on the combination
No published study has tested DSIP, KPV and Selank together, or any two of them as a pair. The data for each component come from separate studies, in different species, models and conditions, and they should not be combined to predict how the blend behaves.
Limits of the evidence
- Almost all data on each component are preclinical. Human studies of DSIP and Selank are few, small and mostly decades old, and much of the Selank work is published only in Russian.
- There are no published data on this blend.
- None of the three components is approved by the FDA for any use.
Forms OmegAmino supplies
| Form | Contents |
|---|---|
| Lyophilized powder | One vial: 10 mg DSIP, 10 mg KPV, 10 mg Selank |
Every batch is third-party tested for identity and purity. Certificates of Analysis are published at omegamino-coas.com. Read more about how we test.
Storage
Store lyophilized peptide sealed and refrigerated, kept cool, dark and away from moisture. We don’t recommend home freezers: their defrost cycles warm and cool the contents repeatedly, which can damage peptides. Once reconstituted, keep the solution refrigerated and use it within the period your protocol specifies.
Related research
- KPV
- Mutant Blend (TB-500, BPC-157 and KPV)
- All research overviews
Researchers with an approved account can order from the shop.
